Literature DB >> 2317404

Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy.

A P Fitzpatrick1, L M Shapiro, A F Rickards, P A Poole-Wilson.   

Abstract

Five generations of an Italian family with an autosomal dominant restrictive cardiomyopathy are described. Members of four generations were examined. Symptoms usually developed in the third or fourth decade but the disease did occur in childhood. Initially the condition was characterised by normal ventricular size and systolic function with increased diastolic filling pressures in both ventricles and consequent bi-atrial enlargement. Cardiac catheterisation showed a left ventricular filling pattern of "dip and plateau". The electrocardiogram typically showed non-specific changes in the ST segment and T wave and changes indicating considerable atrial enlargement, which were confirmed by echocardiography. Light microscopy of two endocardial biopsy specimens showed no specific features but excluded the endomyocardial fibrosis of eosinophilic heart disease, amyloid, and specific heart muscle diseases. At necropsy in one case examined under light microscopy extensive patchy fibrosis was found throughout the endocardium, myocardium, and subepicardium, but there were no features typical of eosinophilic heart disease. Histopathological and biochemical examination of skeletal muscle identified no abnormality. The disease often had an insidious course over five to ten years after presentation. Bundle branch blocks, leading to complete atrioventricular block, however, often occurred and may be the first manifestation. Some individuals who survived into the fifth decade developed a progressive, non-wasting skeletal myopathy.

Entities:  

Mesh:

Year:  1990        PMID: 2317404      PMCID: PMC1024337          DOI: 10.1136/hrt.63.2.114

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  9 in total

Review 1.  The pathology of cardiomyopathies. A critical analysis.

Authors:  E G Olsen
Journal:  Am Heart J       Date:  1979-09       Impact factor: 4.749

Review 2.  Eosinophilia and heart disease.

Authors:  C M Oakley; G J Olsen
Journal:  Br Heart J       Date:  1977-03

3.  Survival after first presentation with endomyocardial fibrosis.

Authors:  P G D'Arbela; T Mutazindwa; A K Patel; K Somers
Journal:  Br Heart J       Date:  1972-04

4.  Clinically significant cardiac amyloidosis. Clinicopathologic findings in 15 patients.

Authors:  L M Buja; N B Khoi; W C Roberts
Journal:  Am J Cardiol       Date:  1970-10       Impact factor: 2.778

5.  Systolic and diastolic ventricular function in cardiac amyloidosis. Studies in six cases diagnosed with endomyocardial biopsy.

Authors:  R H Swanton; I A Brooksby; M J Davies; D J Coltart; B S Jenkins; M M Webb-Peploe
Journal:  Am J Cardiol       Date:  1977-05-04       Impact factor: 2.778

6.  Clinical profile of restrictive cardiomyopathy.

Authors:  J R Benotti; W Grossman; P F Cohn
Journal:  Circulation       Date:  1980-06       Impact factor: 29.690

7.  Hemochromatosis heart disease: an unemphasized cause of potentially reversible restrictive cardiomyopathy.

Authors:  D J Cutler; J M Isner; A W Bracey; C A Hufnagel; P W Conrad; W C Roberts; D M Kerwin; A M Weintraub
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

8.  Idiopathic restrictive cardiomyopathy.

Authors:  R J Siegel; P K Shah; M C Fishbein
Journal:  Circulation       Date:  1984-08       Impact factor: 29.690

9.  Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport.

Authors:  L J Waber; D Valle; C Neill; S DiMauro; A Shug
Journal:  J Pediatr       Date:  1982-11       Impact factor: 4.406

  9 in total
  16 in total

Review 1.  Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Cardiol       Date:  2007-08       Impact factor: 2.882

Review 2.  Clinical screening and genetic testing.

Authors:  Rahul C Deo; Calum A MacRae
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

Review 3.  Precision medicine approach to genetic cardiomyopathy.

Authors:  K Filonenko; H A Katus; B Meder
Journal:  Herz       Date:  2017-08       Impact factor: 1.443

4.  Probable right ventricular dysplasia and patent foramen ovale presenting with cyanosis and clubbing in a patient with characteristics of Noonan syndrome.

Authors:  P Wilmshurst; P Da Costa
Journal:  Br Heart J       Date:  1995-10

5.  Noonan's cardiomyopathy: a non-hypertrophic variant.

Authors:  R A Cooke; J B Chambers; P V Curry
Journal:  Br Heart J       Date:  1994-06

Review 6.  Clinical screening and genetic testing.

Authors:  Rahul C Deo; Calum A MacRae
Journal:  Clin Lab Med       Date:  2010-12       Impact factor: 1.935

7.  Restrictive cardiomyopathies in childhood. Etiologies and natural history.

Authors:  S W Denfield; G Rosenthal; R J Gajarski; J T Bricker; K O Schowengerdt; J K Price; J A Towbin
Journal:  Tex Heart Inst J       Date:  1997

8.  Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.

Authors:  Jens Mogensen; Toru Kubo; Mauricio Duque; William Uribe; Anthony Shaw; Ross Murphy; Juan R Gimeno; Perry Elliott; William J McKenna
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

9.  Restrictive and hypertrophic cardiomyopathies in Noonan syndrome: the overlap syndromes.

Authors:  P T Wilmshurst; D Katritsis
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

Review 10.  The genetics of cardiomyopathies: what clinicians should know.

Authors:  Rahul Deo; Calum A MacRae
Journal:  Curr Heart Fail Rep       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.